Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies - Wikidata - thesis-toulmin - TriplyDB

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

http://www.wikidata.org/entity/Q24626844

about

Features of Polycystic Ovary Syndrome in adolescence Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome PPARG regulates gonadotropin-releasing hormone signaling in LbetaT2 cells in vitro and pituitary gonadotroph function in vivo in mice.Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women.Polycystic ovarian syndrome is accompanied by repression of gene signatures associated with biosynthesis and metabolism of steroids, cholesterol and lipids.Contribution of real-time elastography in diagnosis of polycystic ovary syndrome Anti-Műllerian hormone--a prognostic marker for metformin therapy efficiency in the treatment of women with infertility and polycystic ovary syndrome.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women Should Subclinical Hypothyroidism Be an Exclusion Criterion for the Diagnosis of Polycystic Ovary Syndrome?Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH Obese Neuronal PPARγ Knockout Mice Are Leptin Sensitive but Show Impaired Glucose Tolerance and Fertility.Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies.Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome.Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients.Single nucleotide polymorphisms in the TGF-β1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: a study in Korean women.Current Dilemmas in Defining the Boundaries of Disease.

P2860

Q26782435-765DF3E9-88D6-41F3-8560-662287C92741 Q33948903-F9416E98-6D99-43B6-AE37-5CFB16179C50 Q34019107-F43AB580-9FE6-4E4B-8296-0840FD7DC276 Q34594089-E6CE0E17-0CD8-4E67-BD0F-D16BE9A7EFD3 Q35433045-832A5F79-E21D-453B-B4F3-0D1A092DA092 Q35552267-3CE1FED7-5940-4A32-ABAE-C9C16DF95B71 Q35720950-972991B9-7DC4-4E9B-943F-3F15709FCE37 Q36517284-E2D0C012-6D75-47AC-BBC0-E86C0D89564E Q38641190-ED750BCE-FAE7-4E9B-9666-EEEDDA8B63FA Q38645798-2F5147B9-09ED-42B2-BF9F-6DBA29323157 Q38967761-BBC6AAE7-408C-49E1-B0A1-DFDF412AB6EE Q39152211-33F1D48B-2440-42EE-BEFD-2E17F1BA61F1 Q46042235-80564932-7DE7-4DFD-B46A-9F7AF6BDADBA Q48509726-A594EF23-EA12-4454-9110-AE3CBA0D6BD3 Q50024493-959FB91C-BBAB-4741-B738-407A3EBBFA0A Q50053040-EE9F7E2A-F431-4A97-B79B-493FEFD6F9C1 Q50710287-8ECA5CDA-DB3C-47F0-8987-4FC0104601ED Q51354324-8AB65170-1F08-44AC-8F5F-2F64DD49507E Q52669802-AAB71474-66CD-468B-A429-2BA92C8D5094

P2860

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

http://www.wikidata.org/entity/Q24626844

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

@ast

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

@en

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

@nl

type

label

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

@ast

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

@en

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

@nl

prefLabel

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

@ast

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

@en

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

@nl

P1433

Q24626844-25F7A0CE-C9D1-46BD-977E-699AB5A9F8E9

P1476

Q24626844-D5D64E72-74AC-4A29-9E41-072C692405CE

P2093

Q24626844-0BA44DFE-BB6D-4BDE-8A4E-2203C2692163

Q24626844-69FAE8AD-053D-48B9-986B-B1E46AEDCFC6

Q24626844-CED5B67D-C09E-4339-9054-638B3E9F5175

P2860

Q24626844-05471813-E092-4257-897F-841A5161A5AA

Q24626844-157B94BB-ABA7-439D-9582-5A845751F774

Q24626844-17AC63C6-0602-43AD-B9C2-D2DF8197FD8D

Q24626844-186CF564-72C8-456B-9F73-4BBD9655A64F

Q24626844-1F599076-1772-49E2-9CF6-67E7491CADE5

Q24626844-23C515D2-10BA-4B6C-8306-A1132E8D434D

Q24626844-273F65EA-2844-4DD1-B2D4-64141ABB7C44

Q24626844-2A934F66-5813-4E0C-85E4-B042806CA9F5

Q24626844-2F990CBB-D8AD-416A-95C4-D047C78CD97F

Q24626844-3689E134-A49C-4757-97F8-78D554BDF924

P304

Q24626844-CE8008AD-D33D-4EDE-A51E-D6514FF3FC7F

P31

Q24626844-3A613D92-03F8-4FD6-8AD8-41C744351F58

Q24626844-634946ed-89ff-4920-96cc-83f24d2b556b

P356

Q24626844-9A3BC9A5-85F9-41AA-8354-876E61DF1E86

P407

Q24626844-E03264C5-D536-4BB0-BA9C-AE281353770C

P433

Q24626844-EA40A28E-5C0A-4F6A-BF10-66C151B0AC10

P478

Q24626844-E0D40E1E-2208-4296-8FDB-E9B68DE2846A

P577

Q24626844-AD431881-CD01-46AD-B0A6-288B8A7CF25D

P698

Q24626844-AFA7C071-C2FD-40E7-8479-25DDADF84CCA

P921

Q24626844-8e5c2cbe-1770-4ec9-87cb-6bbf3bd36dcf

Q24626844-DC3CFE42-89DE-46F8-9F35-30F4F3FC3AE9

P932

Q24626844-CE3D33E2-7C45-4904-B05D-5C4DDC87E1F9

P356

S1701-2163(16)32915-2

P1433

Journal of Obstetrics and Gynaecology Canada

P1476

Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies

@en

P2093

Donna R Chizen

http://www.w3.org/2001/XMLSchema#string

Marla E Lujan

http://www.w3.org/2001/XMLSchema#string

Roger A Pierson

http://www.w3.org/2001/XMLSchema#string

P2860

Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

Current concepts in the polycystic ovary syndrome.

Form and function of the corpus luteum during the human menstrual cycle.

Clinical assessment of body hair growth in women.

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

The prevalence and features of the polycystic ovary syndrome in an unselected population.

The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women.

Guidelines of care for acne vulgaris management.

What is polycystic ovary syndrome? Are national views important?

P304

671-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1701-2163(16)32915-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18786289

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

P932

2893212

http://www.w3.org/2001/XMLSchema#string